IP Library Patent Application 13720208
Patent Application
App. No. 13/720,208

FEMININE ANTI-ITCH CLOTH

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/720,208
Abstract

The present invention provides disposable cloths that are designed to reduce itching discomfort when wiped across the vulvar tissue. These disposable cloths are wetted with a composition that includes at least one anesthetic, protectant, buffer, and surfactant. The composition is substantially clear and preferably does not bring about a cooling or stinging sensation when applied to the vulvar tissue. Furthermore, the composition has a pH adapted to vulvar use.

Claims (61)

1 . An anti-itch cloth, for treating itching of the vulvar tissues, comprising:

a cloth wetted with a composition,

the composition comprising:

water,

an anesthetic,

from 5 to 45% of a protectant,

a buffer, and

a surfactant,

where the composition excludes quantities of chemesthetic ingredients sufficient to provide a cooling effect when applied to vulvar tissues.

2 . The cloth of claim 1 , where the composition has a turbidity of from 0.1 to 1 NTU.

3 . The cloth of claim 1 , where the composition has a turbidity of from 0.45 to 0.65 NTU.

4 . The cloth of claim 1 , where the composition has a pH of from 3.4 to 3.9.

5 . The cloth of claim 1 , where the composition has an average pH of about 3.7.

6 . The cloth of claim 1 , where the surfactant comprises less than 10% of the composition.

7 . The cloth of claim 1 , where the surfactant comprises less than 5% of the composition.

8 . The cloth of claim 1 , where the composition comprises at most 0.015% chemesthetic cooling ingredients.

9 . The cloth of claim 1 , where the anesthetic is selected from the group consisting of pramoxine, benzocaine, dibucaine, tetracaine, resorcinol, and mixtures thereof.

10 . The cloth of claim 1 , where the anesthetic comprises from 0.5 to 20% of the composition.

11 . The cloth of claim 1 , where the anesthetic comprises from 0.9 to 1.1% of the composition.

12 . The cloth of claim 1 , where the protectant is selected from the group consisting of glycerin, dimethicone, and mixtures thereof.

13 . The cloth of claim 1 , where the protectant comprises glycerin.

14 . The cloth of claim 1 , where the protectant comprises from 10 to 40% of the composition.

15 . The cloth of claim 1 , where the protectant comprises from 20 to 40% of the composition.

16 . The cloth of claim 1 , where the buffer is selected from the group consisting of citric acid/sodium citrate, benzoic acid/sodium benzoate, acetic acid/sodium acetate, and mixtures thereof.

17 . The cloth of claim 1 , where the buffer comprises from 0.1 to 1% of the composition.

18 - 20 . (canceled)

21 . A composition for treating vulvar tissue, consisting essentially of:

water,

an anesthetic,

from 5 to 45% of a protectant,

a preservative,

a buffer, and

a surfactant.

22 - 28 . (canceled)

29 . A method of forming an anti-itch cloth for treating itching of the vulvar tissues, comprising:

wetting a cloth with an anti-itch composition comprising:

water,

an anesthetic,

from 5 to 45% of a protectant,

a buffer, and

a surfactant, where the composition excludes quantities of ingredients sufficient to provide a cooling effect when applied to vulvar tissues.

30 - 40 . (canceled)

41 . A method for treating vulvar discomfort, comprising:

contacting vulvar tissue with a cloth wetted with an anti-itch composition comprising:

water,

an anesthetic,

from 5 to 45% of a protectant,

a buffer, and

a surfactant, where the composition excludes quantities of chemesthetic ingredients sufficient to provide a cooling effect when applied to vulvar tissues.

42 - 47 . (canceled)

48 . The anti-itch cloth of claim 1 , where the surfactant is the sole surfactant.

49 . The anti-itch cloth of claim 1 , where the composition forms no stable foams.

50 . The composition of claim 21 , where the surfactant is the sole surfactant.

51 . The composition of claim 21 , where the composition forms no stable foams.

52 . The method of claim 29 , where the surfactant is the sole surfactant.

53 . The method of claim 29 , where the composition forms no stable foams.

54 . The method of claim 41 , where the surfactant is the sole surfactant.

55 . The method of claim 41 , where the composition forms no stable foams.

56 . The anti-itch cloth of claim 1 , where the composition comprises from 0.1 to 1% of the surfactant.

57 . The anti-itch cloth of claim 1 , where the composition comprises from 0.24 to 0.36% of the surfactant.

58 . The anti-itch cloth of claim 1 , where the composition comprises from 0.27 to 0.33% of the surfactant.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2015
From: CORRY, BOBBY; HOVDA, RUSS; CASWELL, MICHAEL L.
To: C.B. FLEET COMPANY INCORPORATED
Reel/Frame 035894/0061 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →